ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
The €5.4 million (40m DKK) investment for the MIRAQLE project supports the development of scalable clinically deployable hyperpolarised MRI for early liver cancer diagnostics. NVision, a quantum ...
A newly developed MRI-based scoring system may help identify patients at higher risk of early recurrence after surgical removal of small hepatocellular carcinoma (HCC). The findings, published in ...
Health on MSN
What's the difference between a CT scan and MRI?
Medically reviewed by Rony Kampalath, MD CT scans and MRIs are imaging procedures that help healthcare providers see inside your body.CT scans are generally faster, less expensive, and more widely ...
Calvin Sun was a healthy 37-year-old when a full-body MRI scan showed a cyst in his kidney. Sun saw a urologist who was cautiously optimistic that it wasn’t cancerous and offered him a surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results